Pliant Therapeutics Announces Closing of Upsized Public

SOUTH SAN FRANCISCO, Calif., July 15, 2022 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused...

Related Keywords

New York ,United States ,Edgewood ,Christopher Keenan ,Broadridge Financial Solutions ,Capital Markets ,Jp Morgan Securities ,Pliant Therapeutics Inc ,Nasdaq ,Exchange Commission ,Prospectus Department ,Corporate Communications ,Island Avenue ,Equity Capital Markets ,Pliant Therapeutics ,Private Securities Litigation Reform Act ,Financial Condition ,Annual Report ,Quarterly Report ,Media Contact ,Investor Relations ,Nasdaq Plrx ,Nc ,